MGMT-535G> T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Kang, B. W. [1 ]
Kim, J. G. [1 ]
Chae, Y. S. [1 ]
Lee, S. J. [1 ]
Do, Y. R. [2 ]
Lee, W. S. [3 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Dongsan Med Ctr, Taegu, South Korea
[3] Daegu Fatima Hosp, Ctr Canc, Taegu, South Korea
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [31] Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimen
    Yildiz, R.
    Buyukberber, S.
    Uner, A.
    Yamac, D.
    Coskun, U.
    Kaya, A. O.
    Ozturk, B.
    Yaman, E.
    Benelkli, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 143 - 143
  • [32] PKM2 as a biomarker for sensitivity to oxaliplatin-based chemotherapy in metastatic colorectal cancer (mCRC).
    Papadaki, C.
    Saridaki, Z.
    Tzardi, M.
    Sfakianaki, M.
    Sfakiotaki, G.
    Trypaki, M.
    Messaritakis, I.
    Mavroudis, D.
    Georgoulias, V.
    Sougklakos, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [33] Chemotherapy-Associated Hepatopathy in Korean Colorectal Cancer Liver Metastasis Patients: Oxaliplatin-Based Chemotherapy and Sinusoidal Injury
    Nam, Soo Jeong
    Cho, Jai Young
    Lee, Hye Seung
    Choe, Gheeyoung
    Jang, Ja June
    Yoon, Yoo-Seok
    Han, Ho-Seong
    Kim, Haeryoung
    KOREAN JOURNAL OF PATHOLOGY, 2012, 46 (01) : 22 - 29
  • [34] A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels
    Ng, Say Liang
    Burns, William I.
    Snyder, Raymond D.
    Newnham, Genni M.
    Mclachlan, Sue-Anne
    Liew, Danny
    Dowling, Anthony J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (02) : 172 - 179
  • [35] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Peter H Cashin
    Lana Ghanipour
    Malin Enblad
    David L Morris
    World Journal of Gastrointestinal Oncology, 2020, (05) : 549 - 558
  • [36] Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy
    Gerger, A.
    Zhang, W.
    Yang, D.
    Bohanes, P. O.
    Ning, Y.
    Winder, T.
    Labonte, M. J.
    Wilson, P. M.
    Benhaim, L.
    El-Khoueiry, R.
    Absenger, G.
    El-Khoueiry, A. B.
    Iqbal, S.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer
    Liu, Zhuo
    Kong, Jiangyin
    Kong, Yuanyuan
    Cai, Feng
    Xu, Xiaocheng
    Liu, Jun
    Wang, Shihua
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (11): : 1459 - 1468
  • [38] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Cashin, Peter H.
    Ghanipour, Lana
    Enblad, Malin
    Morris, David L.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (05) : 549 - 558
  • [39] Handy prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer
    Chibaudel, B.
    Tournigand, C.
    Bonnetain, F.
    Andre, T.
    Lledo, G.
    Maindrault-Goebel, F.
    Larsen, A. K.
    Louvet, C.
    de Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
    Ohhara, Yoshihito
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    ONCOTARGETS AND THERAPY, 2015, 8 : 529 - 537
12345